Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
 9 Months Ended
Document And Entity Information [Abstract]
Document Type 10-Q
Document Quarterly Report true
Amendment Flag false
Document Period End Date Sep. 30, 2020
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2020
Document Fiscal Period Focus Q3
Document Transition Report false
Entity File Number 001-34079
Entity Registrant Name REXAHN PHARMACEUTICALS, INC.
Entity Central Index Key 0001228627
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 11-3516358
Entity Address, Address Line One 15245 Shady Grove Road
Entity Address, Address Line Two Suite 455
Entity Address, City or Town Rockville
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20850
City Area Code 240
Local Phone Number 268-5300
Title of 12(b) Security Common Stock, $.0001 par value
Trading Symbol REXN
Security Exchange Name NASDAQ
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Shell Company false
Entity Emerging Growth Company false
Entity Common Stock, Shares Outstanding 4,483,198

Attachments

  • Original document
  • Permalink

Disclaimer

Rexahn Pharmaceuticals Inc. published this content on 29 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 October 2020 13:44:08 UTC